Influence of a non-selective cyclooxygenase (COX) inhibitor and nitric oxide (NO)-releasing aspirin on esophageal mucosal damage in an experimental model of acute reflux esophagitis

Gastroenterologia Polska

Volumn 17, Issue 3, 2010, Pages 187-192

  Pawlik, Michał ^a   Mazurkiewicz Janik, Małgorzata ^a   Pajdo, Robert ^a   Drozdowicz, Danuta ^a   Kwiecień, Sławomir ^a   Brzozowski, Tomasz ^a   Konturek, Stanislaw J ^a   Pawlik, Wiesław W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aspirin; Esophageal blood flow; Glyceryl trinitrate; NO releasing aspirin; Reflux esophagitis

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; HYDROGEN; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CELL ADHESION; CONTROLLED STUDY; ESOPHAGUS MUCOSA; MALE; NEUTROPHIL; NONHUMAN; PYLORUS; RAT; REFLUX ESOPHAGITIS; STOMACH JUICE;

EID: 77956407983     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sifrim D., Mittal R., Fass R, Smut A., Castell D., Tack J., Gregersen H.: Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment. Pharmacol. Ther., 2007, 25, 1003-1015.
2. Essen G.: The epidemiology of gastroesophageal reflux disease: what we know and what we need to know. Am J Gastroenterol 2001, 96, suppl. 8, S16-18.
3. Orlando Roy C.: Current understanding of the mechanisms of gastroesophageal reflux disease. Drugs, 2006, suppl. 1, 1-5.
4. El-Searag H.B.: Time trends of gastroesophageal reflux disease: a systemic review. Clin. Gastroenterol. Hepatol., 2007, 5, 17-26.
5. Oh D.S., Hagen J.A., Fein M.: The impact of reflux composition on mucosal injury and esophageal function. J. Gastrointest. Surg., 2006, 10, 787-797.
6. - secretion in the esophageal submucosal glands. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 288, G736-744.
7. Nagahama K., Yamoto M., Nishio H., Takeuchi K.: Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats. Dig. Dis. Sci., 2006, 51, 303-309.
8. Lans A., Hirschowitz B.I.: Significant role of aspirin use in patients with esophagitis. J. Clin. Gastroenterol., 1991, 13, 622-627.
9. Armstrong H.P., Blower A.L.: Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut, 1987, 28, 527-532.
10. Elliott S.N., McKnight W., Cirino G., Wallace J.L.: A nitric oxide-releasing non steroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology, 1995, 109, 524-530.
11. Davies N.M., Røseth A.G., Appleyard C.B., McKnight W., Del Soldato P., Calignano A., Cirino G., Wallace J.L.: NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment. Pharmacol. Ther., 1997, 11, 69-79.
12. Tashima K., Fujita A., Umeda M., Takeuchi K.: Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4026, in the stomach of diabetic rats. Life Sci., 2000, 67, 1639-1652.
13. Brzozowski T., Konturek P.C., Konturek S.J.: Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc. Res. Tech., 2001, 53, 343-353.
14. Fiorucci S., Santucci C., Gresele P., Del Soldato P., Morelli A.: Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers; a proof of concept endoscopic study. Gastroenterol., 2003, 124, 600-607.
15. Burgaud J.L., Ongini E., Del Soldato P.: Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents. Ann. NY Acad. Sci., 2002, 962, 360-371.
16. Brzozowski T., Konturek P.C., Konturek S.J., Śliwowski Z., Drozdowicz D., Kwiecień S.: Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal antiinflammatory drugs. Dig. Liver Dis., 2000, 32, 583-594.
17. Omura N., Kashiwagi H., Chen G., Suzuki Y., Yano F., Aoki T.: Establishment of surgically induced chronic acid reflux esophagitis in rats. Scand J. Gastroenterol., 1999, 34, 947-953.
18. Brzozowski T., Konturek P.C., Konturek S.J.: Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. Eur. J. Pharmacol., 1999, 385, 47-61.
19. Konturek S.J., Zayachkivska O., Havryluk X.O., Brzozowski T., Śliwoski Z., Pawlik M., Konturek P.C., Czaśnikiewicz-Guzik M., Gzhegotsky M.R., Pawlik W.W.: Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. J. Physiol. Pharmacol., 2007, 58, 371-387.
20. Hayakawa T, Fujiwara Y, Hamaguchi M, Sugawa T, Okuyama M, Sasaki E, Watanabe T, Tominaga K, Oshitani N, Higuchi K, Arakawa T.: Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis. Gut, 2006, 55, 450-456.
21. Brzozowski T., Konturek P.C., Konturek S.J.: Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. Eur. J. Pharmacol., 1999, 385, 47-61.
22. Popławski C., Sosnowski D., Szaflarska-Popławska A., Sarosiek J., McCallum R., Bartuzi Z.: Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model. World J. Gastroenterol., 2006, 12, 1739-1742.
23. Brzozowska I., Targosz A., Śliwowski Z., Kwiecień D., Drozdowicz D., Pajdo R., Konturek P.C., Brzozowski T., Pawlik M., Konturek S.J., Pawlik W.W., Hahn E.G.: Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J. Physiol. Pharmacol., 2004, 55, 773-790.
24. Kwiecien S, Brzozowski T, Konturek PC, Pawlik MW, Pawlik WW, Kwiecien N, Konturek S.J.: Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines. J. Physiol. Pharmacol., 2004, 55, 337-355